Avricore Health AVCRF
OTC AVCRF
$0.03 +0.00 (+0.00%)
At close: Aug 25, 2026 · 4:00 PM EDT

Avricore Health (AVCRF) Amortization of Deferred Charges (2017 - 2021)

Avricore Health (AVCRF) posted quarterly Amortization of Deferred Charges of $30369.8 for Q1 2021, up 235.72% year-over-year from $9046.2 in Q1 2020, and down 13.79% quarter-over-quarter from $35226.2 in Q4 2020.

Avricore Health (AVCRF) Amortization of Deferred Charges (2017 - 2021) Analysis & Trends

Avricore Health (AVCRF) has reported Amortization of Deferred Charges for 2 consecutive years, with $30369.8 the latest figure, recorded in Q1 2021.

  • In Q1 2021, Amortization of Deferred Charges rose 235.72% year-over-year to $30369.8; the TTM figure through Dec 2021 stood at $30369.8 (down 71.59% YoY), while the FY2021 annual figure was $30671.8, down 71.56% from the prior year.
  • Amortization of Deferred Charges declined to $30369.8 in Q1 2021 per AVCRF's latest filing, from $35226.2 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $59601.0 in Q2 2020 and bottomed at -$22376.8 in Q1 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Avricore Health 3.04 Mn 3.01 Mn -6.20 Bn

Historic Data

Download Data
DateValue
Mar 31, 2021 30,369.83
Mar 31, 2021 30,369.83
Dec 31, 2020 35,226.22
Dec 31, 2020 35,226.22
Sep 30, 2020 34,461.71
Sep 30, 2020 34,461.71
Jun 30, 2020 59,601.02
Jun 30, 2020 59,601.02
Mar 31, 2020 -22,376.84
Mar 31, 2020 -22,376.84
Dec 31, 2017 -352,416.97
Dec 31, 2017 -352,416.97